Results 141 to 150 of about 7,176,843 (353)

Tobacco Quitline Engagement and Outcomes among Primary Care Patients Reporting use of Tobacco or Dual Tobacco and Cannabis: An Observational Study [PDF]

, 2020
Jennifer B. McClure, Gwen T. Lapham
openalex   +1 more source

Patient-reported outcome measures [PDF]

Journal of the Royal Society of Medicine, 2007
openaire   +2 more sources

The Patient-Reported Outcomes Measurement Information System (PROMIS): Progress of an NIH Roadmap Cooperative Group During its First Two Years

Medical Care, 2007
D. Cella, S. Yount, N. Rothrock, R. Gershon, K. Cook, B. Reeve, D. Ader, J. Fries, B. Bruce, M. Rose   +9 more
semanticscholar   +1 more source

PICALM::MLLT10 translocated leukemia

FEBS Letters, EarlyView.
This comprehensive review of PICALM::MLLT10 translocated acute leukemia provides an in‐depth review of the structure and function of CALM, AF10, and the fusion oncoprotein (1). The multifaceted molecular mechanisms of oncogenesis, including nucleocytoplasmic shuttling (2), epigenetic modifications (3), and disruption of endocytosis (4), are then ...
John M. Cullen, Antonia C. Nakatsugawa, Natalie Barton, Henry Haines, Gary S. Stein, Janet L. Stein, Daniel S. Wechsler, Jessica L. Heath   +7 more
wiley   +1 more source

Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment

Journal of the American Medical Association (JAMA), 2017
E. Basch, A. Deal, A. Dueck, H. Scher, M. Kris, C. Hudis, D. Schrag   +6 more
semanticscholar   +1 more source

Inhibiting stearoyl‐CoA desaturase suppresses bone metastatic prostate cancer by modulating cellular stress, mTOR signaling, and DNA damage response

FEBS Letters, EarlyView.
Bone metastasis in prostate cancer (PCa) patients is a clinical hurdle due to the poor understanding of the supportive bone microenvironment. Here, we identify stearoyl‐CoA desaturase (SCD) as a tumor‐promoting enzyme and potential therapeutic target in bone metastatic PCa.
Alexis Wilson, Mackenzie K Herroon, Shane Mecca, Laimar C Garmo, Jacob Lindquist, Shrila Rajendran, Steve M. Patrick, Izabela Podgorski   +7 more
wiley   +1 more source

COPD exacerbations and patient-reported outcomes according to post-bronchodilator FEV1 – a post-hoc analysis of pooled data [PDF]

, 2023
Chee-Shee Chai, Diana-Leh-Ching Ng, Sumastika Bt Mos, Muhammad Amin Ibrahim, Tan Seng Beng, Yong‐Kek Pang, Chong Kin Liam   +6 more
openalex   +1 more source

Nicotinamide N‐methyltransferase promotes drug resistance in lung cancer, as revealed by nascent proteomic profiling

Molecular Oncology, EarlyView.
AZD9291 has shown promise in targeted cancer therapy but is limited by resistance. In this study, we employed metabolic labeling and LC–MS/MS to profile time‐resolved nascent protein perturbations, allowing dynamic tracking of drug‐responsive proteins. We demonstrated that increased NNMT expression is associated with drug resistance, highlighting NNMT ...
Zhanwu Hou, Zhen Wang, Fei Yang, Xiao Han, Lei Li, Huadong Liu   +5 more
wiley   +1 more source

Psychometric Evaluation of a New Patient-Reported Outcome (PRO) Symptom Diary for Varicose Veins: VVSymQ® Instrument [PDF]

, 2016
David Wright, Jean Paty, Diane M. Turner‐Bowker, Andrew W. Bradbury   +3 more
openalex   +1 more source

The Patient Reported Outcomes as a Clinical Tool (PROACT) Pilot Study: What Can be Gained by Sharing Computerized Patient-Reported Mental Health and Substance Use Symptoms with Providers in HIV Care?

, 2021
Sarah M. Jabour, Geetanjali Chander, Kristin A. Riekert, Jeanne Keruly, Kayla Herne, Heidi E. Hutton, Mary Catherine Beach, Bryan Lau, Richard D. Moore, Anne K. Monroe   +9 more
openalex   +2 more sources